BRANDI SAGERS: Open Payments
NPI 1265121065 · PUNTA GORDA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,082 in 96 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,733 · 2025 $2,082
Food & beverage: $1,971Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $306 |
| Neurocrine BioSciences, Inc. | 13 | $273 |
| Alkermes, Inc. | 19 | $270 |
| E.R. Squibb & Sons, L.L.C. | 13 | $256 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $250 |
| ABBVIE INC. | 4 | $180 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| Vanda Pharmaceuticals Inc. | 4 | $96 |
| Braeburn Inc. | 3 | $75 |
| Axsome Therapeutics, Inc. | 3 | $71 |
Products named: INGREZZA, COBENFY, CAPLYTA, ARISTADA, VRAYLAR, UZEDY, FANAPT, REXULTI.
Industry payments across FL — which companies pay providers there.
